Uncover MA market drivers with 🤖 xAI-powered market insights !

2022 AEP
Findings Report

October 21, 2021       Report

The Medicare Advantage (MA) ecosystem is maturing at a rapid pace. Each year Payors attempt strategic investments into their Plan Benefits Packages (PBP) to gain a competitive edge. Often, Payors elect to follow industry trends, both regional and national, while others attempt to become Mavericks of the market. Regardless of the direction, staying in tune with ongoing, and predicted trends is an indication of future opportunities for a constantly growing market. As of October 2021, enrollment in MA has exceeded 27.5 million, a 9.9% increase over the 25 million enrolled in a Part-C Plan last year.  To meet the growing demand, Payors across the country increased the number of plans available by 452 for 2022, a rise of 9%.

This report highlights the major Plan & Benefit factors for the MA market as provided by the AEP data release by CMS earlier this month. This includes year-over-year (YoY) trends and variations of the MA market and cuts by plan type, cost structures, and benefit categories. Beginning with an overview of national-level variations for each primary plan type, we then dive deeper into plan design, where we examine beneficiary cost factors and benefit inclusions.

National Overview

State Overview

MA/MAPD Overview

SNP Type Overview

Plan Type Overview (Non-SNP)

HMO and PPO Deep Dive (Non-SNP)

Premium

Zero Premium Expansion

Drug Deductible

In Network MOOP

Benefit Overview (Non-SNP)

Major Expansions

Many Medicare Advantage organizations, both large and small, focus heavily on market expansion as their catalyst for growth. With long term growth being at the forefront of every organization, two Payors, Centene Corporation and Molina Healthcare are seen as the most aggressive.

Glossary

Share this insight!

Request A Personalized Demo
Let us show you how HealthWorksAI can optimize your Medicare Advantage product design efforts at every stage through actionable insights by leveraging public and private healthcare data.